Working… Menu
Trial record 1 of 2 for:    hm06
Previous Study | Return to List | Next Study

Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities ((MARGARET))

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04683250
Recruitment Status : Recruiting
First Posted : December 24, 2020
Last Update Posted : September 16, 2021
ICON Clinical Research
Information provided by (Responsible Party):
Helsinn Healthcare SA

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : August 2024